Exthera Medical Corporation

This study tested a device called Seraph 100, a blood filter that removes the COVID-19 virus from the bloodstream. It involved 42 severely ill adults with COVID-19 who had organ failure. The goal was to see if the filter could reduce organ damage and improve survival.

This study planned to test a blood-filtering device called Seraph 100 in 100 adults with long COVID. Participants would receive two filtering sessions on consecutive days and be checked after 3 days and 4 weeks. However, the study was withdrawn before any patients were enrolled, …

This study tests a blood purification device in 15 critically ill adults with septic shock (a severe infection causing low blood pressure). The goal is to see if filtering the blood can help patients recover faster and leave the ICU sooner. The treatment is given alongside standa…